Claire Palles Selected Research

Claire Palles Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 10/2012
15	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2011
5	Obesity 03/2024 - 01/2020
5	Adenocarcinoma 01/2021 - 10/2012
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 07/2013
3	Dihydropyrimidine Dehydrogenase Deficiency 01/2024 - 12/2015
3	COVID-19 01/2022 - 01/2020
3	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 10/2012
3	Breast Neoplasms (Breast Cancer) 05/2012 - 01/2009
2	Carcinogenesis 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Genomic Instability 01/2018 - 07/2013
1	Hand-Foot Syndrome 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Vomiting 11/2021
1	Neutropenia 11/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2021
1	Abdominal Obesity 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Microsatellite Instability 01/2019
1	Genetic Risk Score 01/2017
1	Pediatric Obesity 07/2016
1	Carcinoma (Carcinomatosis) 04/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Dyskinesias (Dyskinesia) 01/2016
1	Hiatal Hernia 10/2012

Drug/Important Bio-Agent (IBA)

5	Exonucleases (3' 5' Exonuclease)IBA 10/2021 - 07/2013
4	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2024 - 01/2020
4	LipidsIBA 03/2024 - 01/2021
4	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 07/2013
3	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 07/2013
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2024 - 12/2015
2	XELOXIBA 01/2022 - 11/2021
2	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 01/2022 - 01/2020
2	25-hydroxyvitamin DIBA 11/2021 - 01/2020
2	Vitamin D FDA LinkGeneric 11/2021 - 10/2019
2	hydroxide ionIBA 11/2021 - 10/2019
2	CholesterolIBA 01/2021 - 01/2017
2	Insulin-Like PeptidesIBA 01/2021 - 01/2009
2	Hormones (Hormone)IBA 05/2012 - 01/2009
2	SteroidsIBA 05/2012 - 01/2009
1	Immune Checkpoint InhibitorsIBA 12/2022
1	Cetuximab (Erbitux)FDA Link 11/2021
1	HDL CholesterolIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Biological FactorsIBA 01/2020
1	CalciumIBA 01/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2020
1	SeleniumIBA 01/2020
1	Thymidylate SynthaseIBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	3' Untranslated Regions (3' UTR)IBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2019
1	MutL Protein Homolog 1IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2017
1	Dietary Fats (Dietary Fat)IBA 10/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 10/2016
1	ORALIT (ORS)IBA 07/2016
1	Tumor Biomarkers (Tumor Markers)IBA 02/2016
1	mouse RECS1 proteinIBA 01/2016
1	DNA replicaseIBA 07/2015
1	Granzymes (Granzyme)IBA 07/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	ProdrugsIBA 01/2015
1	AcidsIBA 10/2012
1	Cytochrome P-450 CYP3AIBA 05/2012
1	Estrone FDA Link 05/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 06/2011
1	Estrogen Receptor alphaIBA 03/2011
1	ProlactinIBA 01/2009

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 04/2016
6	Therapeutics 12/2022 - 01/2017
1	Chemoprevention 01/2023
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 04/2016
1	Adjuvant Chemotherapy 04/2016